These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major. Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334 [TBL] [Abstract][Full Text] [Related]
13. Insulin and glucagon responses to provocation with glucose and arginine in prepubertal children with thalassemia major before and after long-term blood transfusion. Soliman AT; el Banna N; alSalmi I; Asfour M J Trop Pediatr; 1996 Oct; 42(5):291-6. PubMed ID: 8936961 [TBL] [Abstract][Full Text] [Related]
14. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece. Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695 [TBL] [Abstract][Full Text] [Related]
15. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment. Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112 [TBL] [Abstract][Full Text] [Related]
16. Intravenous chelation therapy during transplantation for thalassemia. Gaziev D; Giardini C; Angelucci E; Polchi P; Galimberti M; Baronciani D; Erer B; Maiello A; Lucarelli G Haematologica; 1995; 80(4):300-4. PubMed ID: 7590497 [TBL] [Abstract][Full Text] [Related]
17. [Therapeuetic management of patients with thalassemia major]. Thuret I Bull Soc Pathol Exot; 2001 May; 94(2):95-7. PubMed ID: 11475036 [TBL] [Abstract][Full Text] [Related]
18. Alpha- and Beta-thalassemia: Rapid Evidence Review. Baird DC; Batten SH; Sparks SK Am Fam Physician; 2022 Mar; 105(3):272-280. PubMed ID: 35289581 [TBL] [Abstract][Full Text] [Related]
19. [The evolutionary effects of therapy on the skeletal lesions in beta-thalassemia]. Orzincolo C; Castaldi G; Bariani L; Scutellari PN Radiol Med; 1994 Apr; 87(4):381-8. PubMed ID: 8190918 [TBL] [Abstract][Full Text] [Related]
20. Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience. Pinto VM; Poggi M; Russo R; Giusti A; Forni GL Blood Rev; 2019 Nov; 38():100594. PubMed ID: 31416718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]